{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:24:08Z","timestamp":1761823448955},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/moo.0b013e3283506870","type":"journal-article","created":{"date-parts":[[2012,1,26]],"date-time":"2012-01-26T08:42:20Z","timestamp":1327567340000},"page":"130-136","source":"Crossref","is-referenced-by-count":5,"title":["Cytogenetic analysis of skull base tumors"],"prefix":"10.1097","volume":"20","author":[{"given":"Ziv","family":"Gil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan M.","family":"Fliss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hed.20741","article-title":"Cytogenetic analysis of 101 skull base tumors.","volume":"30","author":"Gil","year":"2008","journal-title":"Head Neck"},{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01053042","article-title":"Cytogenetics of cranial base tumors.","volume":"20","author":"Gollin","year":"1994","journal-title":"J Neurooncol"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1126\/science.1957167","article-title":"Chromosome aberrations and cancer.","volume":"254","author":"Solomon","year":"1991","journal-title":"Science"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/372143a0","article-title":"Chromosomal translocations in human cancer.","volume":"372","author":"Rabbitts","year":"1994","journal-title":"Nature"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.otohns.2005.10.055","article-title":"Cytogenetic analysis of sinonasal carcinomas.","volume":"134","author":"Gil","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/cncr.11931","article-title":"Comparative genomic hybridization in primary sinonasal adenocarcinomas.","volume":"100","author":"Ariza","year":"2004","journal-title":"Cancer"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(03)00002-5","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms.","volume":"143","author":"Sandberg","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/gcc.1184","article-title":"Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.","volume":"32","author":"Scheil","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/path.1023","article-title":"Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.","volume":"196","author":"Tallini","year":"2002","journal-title":"J Pathol"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cancergencyto.2004.01.031","article-title":"Cytogenetic analysis of three variants of clival chordoma.","volume":"154","author":"Gil","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"R12-10-20210206","first-page":"E6","article-title":"Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors Neurosurg F","volume":"10","author":"Sawyer","year":"2001","journal-title":"ocus"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/1097-0215(20000701)87:1<68::AID-IJC10>3.0.CO;2-V","article-title":"A tumor suppressor locus in familial and sporadic chordoma maps to 1p36.","volume":"87","author":"Miozzo","year":"2000","journal-title":"Int J Cancer"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ng.454","article-title":"T (brachyury) gene duplication confers major susceptibility to familial chordoma.","volume":"41","author":"Yang","year":"2009","journal-title":"Nat Genet"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.2816","article-title":"Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.","volume":"223","author":"Presneau","year":"2011","journal-title":"J Pathol"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1096-911X(20010201)36:2<259::AID-MPO1063>3.0.CO;2-K","article-title":"Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.","volume":"36","author":"Gordon","year":"2001","journal-title":"Med Pediatr Oncol"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1096-911X(199803)30:3<156::AID-MPO5>3.0.CO;2-G","article-title":"Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma.","volume":"30","author":"Kullendorff","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0165-4608(86)90152-4","article-title":"Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11).","volume":"23","author":"Limon","year":"1986","journal-title":"Cancer Genet Cytogenet"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1073\/pnas.84.7.1981","article-title":"Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma.","volume":"84","author":"Turc-Carel","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(01)00626-4","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma.","volume":"133","author":"Sandberg","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ng0894-502","article-title":"Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma.","volume":"7","author":"Clark","year":"1994","journal-title":"Nat Genet"},{"key":"R22-10-20210206","first-page":"1447","article-title":"The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome.","volume":"9","author":"Shipley","year":"1994","journal-title":"Oncogene"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/hmg\/6.9.1559","article-title":"The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies.","volume":"6","author":"Brett","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/modpathol.3880083","article-title":"Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.","volume":"13","author":"Inagaki","year":"2000","journal-title":"Mod Pathol"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ijc.2910600512","article-title":"Karyotypic features of malignant tumors of the nasal cavity and paranasal sinuses.","volume":"60","author":"Jin","year":"1995","journal-title":"Int J Cancer"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1750-3639.2004.tb00048.x","article-title":"CGH pattern of esthesioneuroblastoma and their metastases.","volume":"14","author":"Bockmuhl","year":"2004","journal-title":"Brain Pathol"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-4608(01)00659-8","article-title":"Analysis of cytogenetic aberrations in esthesioneuroblastomas by comparative genomic hybridization.","volume":"136","author":"Riazimand","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-4608(91)90198-4","article-title":"Trisomy 8 in primary esthesioneuroblastoma.","volume":"57","author":"VanDevanter","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjc.6690734","article-title":"Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewings group.","volume":"81","author":"Mezzelani","year":"1999","journal-title":"Br J Cancer"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-9896(200001)190:1<31::AID-PATH505>3.0.CO;2-#","article-title":"Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.","volume":"190","author":"Mertens","year":"2000","journal-title":"J Pathol"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-4608(03)00036-0","article-title":"Two novel translocations, t(2;4)(q35;q31) and t(X;12)(q22;q24), as the only karyotypic abnormalities in a malignant peripheral nerve sheath tumor of the skull base.","volume":"145","author":"Gil","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"R32-10-20210206","first-page":"826","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.","volume":"75","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2.","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/hmg\/8.2.267","article-title":"Increased expression of the NF2 tumor suppressor gene product, merlin, impairs cell motility, adhesion and spreading.","volume":"8","author":"Gutmann","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11060-010-0412-5","article-title":"Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization.","volume":"103","author":"Koutsimpelas","year":"2011","journal-title":"J Neurooncol"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<440::AID-CNCR27>3.0.CO;2-5","article-title":"A role for telomeric and centromeric instability in the progression of chromosome aberrations in meningioma patients.","volume":"88","author":"Sawyer","year":"2000","journal-title":"Cancer"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000056986","article-title":"Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases.","volume":"93","author":"Zang","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas.","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat Genet"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/hmg\/1.1.7","article-title":"A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter.","volume":"1","author":"Heutink","year":"1992","journal-title":"Hum Mol Genet"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00217356","article-title":"Analysis of a second family with hereditary nonchromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q.","volume":"91","author":"Mariman","year":"1993","journal-title":"Hum Genet"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"key":"R42-10-20210206","first-page":"121","article-title":"Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23.","volume":"60","author":"Baysal","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s100480050078","article-title":"PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma.","volume":"2","author":"Niemann","year":"1999","journal-title":"Neurogenetics"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tem.2003.08.004","article-title":"On the association of succinate dehydrogenase mutations with hereditary paraganglioma.","volume":"14","author":"Baysal","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00005537-200008000-00023","article-title":"Molecular pathogenesis in sporadic head and neck paraganglioma.","volume":"110","author":"Bikhazi","year":"2000","journal-title":"Laryngoscope"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199801153380303","article-title":"SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.","volume":"338","author":"Kawai","year":"1998","journal-title":"N Engl J Med"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.1995.03520310051029","article-title":"Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas.","volume":"273","author":"Barr","year":"1995","journal-title":"JAMA"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/1097-0142(20001101)89:9<1992::AID-CNCR16>3.0.CO;2-R","article-title":"A reverse transcriptase-polymerase chain reaction assay in the diagnosis of soft tissue sarcomas.","volume":"89","author":"Naito","year":"2000","journal-title":"Cancer"}],"container-title":["Current Opinion in Otolaryngology &amp; Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOO.0b013e3283506870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:22:19Z","timestamp":1620966139000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00020840-201204000-00010"}},"subtitle":["where do we stand?"],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/moo.0b013e3283506870","relation":{},"ISSN":["1068-9508"],"issn-type":[{"value":"1068-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}